Búsqueda de un ensayo clínico
Otra(s) opcion(es) de búsqueda
12 Resultado(s)
Ensayo clínico en reclutamiento
= ; Ensayos clínico en curso
=
; Ensayo clínico finalizado
=
; Financiado por un miembro del IRDiRC =
; Miembro de una ERN =
Ensayo(s) clínico(s) nacional(es)

ALEMANIA
Baden-Württemberg
FREIBURG

A Phase I/II study of Azacitidine (Vidaza®) in pediatric patients with newly diagnosed or relapsed high-grade pediatric Myelodysplastic Syndromes or Juvenile Myelomonocytic Leukaemia - DE
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Pädiatrische Hämatologie und Onkologie

ALEMANIA
Baden-Württemberg
FREIBURG

A Phase 2, multicenter, open-label study to evaluate the pharmacokinetics, pharmacodynamics, safety and activity of Azacitidine and to compare Azacitidine to historical controls in pediatric subjects with newly diagnosed advanced Myelodysplastic Syndrome or Juvenile Myelomonocytic Leukemia before hematopoietic stem cell transplantation - DE
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Pädiatrische Hämatologie und Onkologie

AUSTRIA
WIEN
WIEN
A Phase I/II study of Azacitidine (Vidaza®) in pediatric patients with newly diagnosed or relapsed high-grade pediatric MDS or JMML - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde

AUSTRIA
WIEN
WIEN
Clinical Phase II Trial to Describe the Safety and Efficacy of Treosulfan-based Conditioning Therapy Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Paediatric Patients With Haematological Malignancies - AT
St. Anna Kinderspital
Zentrum für Kinder- und Jugendheilkunde

ESPAÑA
Madrid
MADRID

Estudio de fase I/II de azacitidina (vidaza®) en pacientes pediátricos con síndrome mielodisplásico (SMD) o leucemia mielomonocítica juvenil (LMMJ) de nuevo diagnóstico, avanzado, o en recaída
Hospital Infantil Universitario Niño Jesús
Servicio de Hematología y Hemoterapia

FRANCIA
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
A Phase 2, multicenter, open-label study to evaluate the pharmacokinetics, pharmacodynamics, safety and activity of azacitidine and to compare azacitidine to historical controls in pediatric subjects with newly diagnosed advanced myelodysplastic syndrome or juvenile myelomonocytic leukemia before hematopoietic stem cell transplantation - FR
Institution: Information not provided - FR

PAISES BAJOS (LOS)
Zuid-Holland
ROTTERDAM

COMPARE 60/80 HBR: Comparison of the Supraflex Cruz 60 Micron Stent Strut Versus the Ultimaster Tansei 80 Micron Stent Strut in High Bleeding Risk PCI Population
Maasstad Ziekenhuis
Polikliniek Cardiologie

REINO UNIDO (EL)
Greater London
LONDON
UK Haplo v1.0: A UK multicentre phase II study of haploidentical stem cell transplantation in patients with haematological malignancies
Guy's Hospital
Department of Haematology

BELGICA
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique

ITALIA
LAZIO
ROMA
An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Refractory Leukemias or Solid Tumors in Pediatric Participants - IT
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
U.O. di Oncoematologia
Ensayo(s) clínico(s) multinacional(es)

ESTADOS UNIDOS
California
ARCADIA
A Randomized Phase II Study Comparing Two Different Conditioning Regimens Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) for Children With Juvenile Myelomonocytic Leukemia (JMML)
Children's Oncology Group

ESPAÑA
Madrid
COLMENAR VIEJO